Advertisement
Screener

Establishment Labs Holdings Inc. (ESTA) Operating Lease, Right-of-Use Asset, Amortization Expense

2.7 / 5 stars · 42/79 Roast Me

Establishment Labs Holdings Inc. Operating Lease, Right-of-Use Asset, Amortization Expense

Establishment Labs Holdings Inc. (ESTA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $461.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-07

  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $247.00K, a 2.49% increase year-over-year.
  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $214.00K, a 7.36% decline year-over-year.
  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $285.00K, a 19.25% increase year-over-year.
  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $154.00K, a 22.22% decline year-over-year.
  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $911.00K, a 22.61% increase from fiscal 2024.
  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $743.00K, a 3.63% increase from fiscal 2023.
  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $717.00K, a 52.88% increase from fiscal 2022.
  • Establishment Labs Holdings Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $469.00K, a 15.52% increase from fiscal 2021.
Period endOperating Lease, Right-of-Use Asset, Amortization Expense 3 monthOperating Lease, Right-of-Use Asset, Amortization Expense 6 monthOperating Lease, Right-of-Use Asset, Amortization Expense 9 monthOperating Lease, Right-of-Use Asset, Amortization Expense 12 month
2026-06-30$247.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$461.00K
10-Q · filed 2026-08-07
$746.00K
derived: sum of 3 quarters · filed 2026-08-07
$900.00K
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$214.00K
10-Q · filed 2026-05-08
$499.00K
derived: sum of 2 quarters · filed 2026-05-08
$653.00K
derived: sum of 3 quarters · filed 2026-05-08
$894.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$285.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$439.00K
derived: sum of 2 quarters · filed 2026-02-27
$680.00K
derived: sum of 3 quarters · filed 2026-08-07
$911.00K
10-K · filed 2026-02-27
2025-09-30$154.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$395.00K
derived: sum of 2 quarters · filed 2026-08-07
$626.00K
10-Q · filed 2025-11-07
$865.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$241.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$472.00K
10-Q · filed 2026-08-07
$711.00K
derived: sum of 3 quarters · filed 2026-08-07
$909.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$231.00K
10-Q · filed 2026-05-08
$470.00K
derived: sum of 2 quarters · filed 2026-05-08
$668.00K
derived: sum of 3 quarters · filed 2026-05-08
$829.00K
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$239.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$437.00K
derived: sum of 2 quarters · filed 2026-02-27
$598.00K
derived: sum of 3 quarters · filed 2026-02-27
$743.00K
10-K · filed 2026-02-27
2024-09-30$198.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$359.00K
derived: sum of 2 quarters · filed 2025-11-07
$504.00K
10-Q · filed 2025-11-07
$679.00K
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$161.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$306.00K
10-Q · filed 2025-08-07
$481.00K
derived: sum of 3 quarters · filed 2026-02-27
$664.00K
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$145.00K
10-Q · filed 2025-05-09
$320.00K
derived: sum of 2 quarters · filed 2026-02-27
$503.00K
derived: sum of 3 quarters · filed 2026-02-27
$685.00K
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$175.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$358.00K
derived: sum of 2 quarters · filed 2026-02-27
$540.00K
derived: sum of 3 quarters · filed 2026-02-27
$717.00K
10-K · filed 2026-02-27
2023-09-30$183.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$365.00K
derived: sum of 2 quarters · filed 2024-11-12
$542.00K
10-Q · filed 2024-11-12
$700.00K
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$182.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$359.00K
10-Q · filed 2024-08-07
$517.00K
derived: sum of 3 quarters · filed 2025-02-28
$641.00K
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$177.00K
10-Q · filed 2024-05-09
$335.00K
derived: sum of 2 quarters · filed 2025-02-28
$459.00K
derived: sum of 3 quarters · filed 2025-02-28
$551.00K
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$158.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$282.00K
derived: sum of 2 quarters · filed 2025-02-28
$374.00K
derived: sum of 3 quarters · filed 2025-02-28
$469.00K
10-K · filed 2025-02-28
2022-09-30$124.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$216.00K
derived: sum of 2 quarters · filed 2023-11-08
$311.00K
10-Q · filed 2023-11-08
$412.00K
derived: sum of 4 quarters · filed 2024-03-04
2022-06-30$92.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$187.00K
10-Q · filed 2023-08-09
$288.00K
derived: sum of 3 quarters · filed 2024-03-04
$389.00K
derived: sum of 4 quarters · filed 2024-03-04
2022-03-31$95.00K
10-Q · filed 2023-05-10
$196.00K
derived: sum of 2 quarters · filed 2024-03-04
$297.00K
derived: sum of 3 quarters · filed 2024-03-04
$400.00K
derived: sum of 4 quarters · filed 2024-03-04
2021-12-31$101.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04
$202.00K
derived: sum of 2 quarters · filed 2024-03-04
$305.00K
derived: sum of 3 quarters · filed 2024-03-04
$406.00K
10-K · filed 2024-03-04
2021-09-30$101.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$204.00K
derived: sum of 2 quarters · filed 2022-11-09
$305.00K
10-Q · filed 2022-11-09
$412.00K
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$103.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$204.00K
10-Q · filed 2022-08-09
$311.00K
derived: sum of 3 quarters · filed 2023-03-01
$407.00K
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$101.00K
10-Q · filed 2022-05-10
$208.00K
derived: sum of 2 quarters · filed 2023-03-01
$304.00K
derived: sum of 3 quarters · filed 2023-03-01
$385.00K
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$107.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$203.00K
derived: sum of 2 quarters · filed 2023-03-01
$284.00K
derived: sum of 3 quarters · filed 2023-03-01
$363.00K
10-K · filed 2023-03-01
2020-09-30$96.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$177.00K
derived: sum of 2 quarters · filed 2021-11-09
$256.00K
10-Q · filed 2021-11-09
2020-06-30$81.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$160.00K
10-Q · filed 2021-07-30
2020-03-31$79.00K
10-Q · filed 2021-05-06
2019-12-31$0.00
10-K · filed 2022-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85